Last reviewed · How we verify
NCT04653103: CONNECT
NASH in Subjects With Different Classes of Obesity
trial testing Liver biopsy in NASH - Nonalcoholic Steatohepatitis in 500 participants. Status unknown.
25 January 2021
Quick facts
| Lead sponsor | Catholic University of the Sacred Heart |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 20 November 2020 |
| Primary completion | 25 January 2021 |
| Estimated completion | 25 January 2023 |
| Sites | 2 locations across Italy |
Drugs / interventions tested
- Liver biopsy — full drug profile →
Conditions studied
- NASH - Nonalcoholic Steatohepatitis — all drugs for NASH - Nonalcoholic Steatohepatitis →
- NAFLD — all drugs for NAFLD →
- Obesity — all drugs for Obesity →
- Obesity, Morbid — all drugs for Obesity, Morbid →
Sponsor
Catholic University of the Sacred Heart
Who can join
Adults 19 to 69, any sex, with NASH - Nonalcoholic Steatohepatitis or NAFLD. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is an observational trial on 500 subjects. The purpose of this trial is to assess the prevalence of non-alcoholic steatohepatitis (NASH) in subjects with different classes of obesity.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04653103
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Liver biopsy
Trials testing the same drug.
- NCT07191561 — Hepatic Lipid Metabolism-Alcohol Use Disorder · not yet recruiting
- NCT06592820 — Endoscopic Ultrasound Shear Wave Elastography Study · recruiting
- NCT06779058 — MR Elastography for Assessing Liver Fibrosis in Chronic Hepatitis B · recruiting
- NCT06470997 — Specific Biomarkers of Immune-mediated Hepatitis Secondary to Immune Checkpoint Inhibitors · recruiting
- NCT05678582 — Hepatic Steatosis and Chronic Hepatitis B Virus · completed
Other recruiting trials for NASH - Nonalcoholic Steatohepatitis
Currently open trials in the same condition.
- NCT05499949 — The Franciscus Obesity NASH Study · active not recruiting
- NCT05023044 — Nonalcoholic Fatty Liver Disease in HIV Database · active not recruiting
- NCT04232566 — Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity · recruiting
- NCT05165446 — Novel MRE Technique to Assess a Risk Factor for Liver Cancer · active not recruiting
- NCT04697810 — Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH) · Phase 2 · recruiting
Other Catholic University of the Sacred Heart trials
Trials by the same sponsor.
- NCT07476599 — The OB-WELL Project, a Randomized Controlled Trial of an Internet-Based Self-Help System for Psychological Support in Ob · NA · not yet recruiting
- NCT07516392 — Study of a Polygenic Risk Score to Predict the Risk of Pancreatic Ductal Adenocarcinoma · NA · not yet recruiting
- NCT07140705 — Personalized Virtual Reality for Promoting Well-Being and Psychological Flexibility in General Practitioners · NA · completed
- NCT06992453 — Multi-omics Dissection of Gut Microbiome Engraftment During FMT · NA · not yet recruiting
- NCT06852183 — Restructuring Body Experience in Anorexia Nervosa: Virtual Reality Functionality-Focused Mirror Exposure · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04653103 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Catholic University of the Sacred Heart
- Last refreshed: 18 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04653103.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing